Celltrion | 068270 - Sales Revenues

Stock Price
239,500.00
Daily Change
-2,500.00 -1.03%
Monthly
13.24%
Yearly
31.09%
Q1 Forecast
232,247.40

Celltrion reported KRW1.33T in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Akebia Therapeutics USD 57.34M 10.84M Mar/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 18.42M 14K Jun/2025
Celltrion KRW 1.33T 300B Mar/2026
Dianthus Therapeutics USD 396K 203K Sep/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Moderna USD 678M 342M Dec/2025
Organon & Co USD 1.51B 90M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.7B 60M Dec/2025
Xeris Pharmaceuticals USD 74.38M 2.84M Sep/2025